The control of Norovirus outbreaks is a key priority for many hospitals. Diarrhea and vomiting resulting from Norovirus outbreaks cause major operational, financial and reputational challenges each winter.
It is difficult to acheive efficacious and consistant decontamination of Norovirus through the manual cleaning of hospital rooms and equipment. Recent published data suggest that Norovirus and surrogates will survive for many days - representing an ongoing source of potential cross-infection.
The Bioquell Norovirus Suppression Program has been developed to overcome issues associated with the speed of Norovirus onset, the scale of environmental contamination and the operational issues it causes.
Each Norovirus Suppression Program is tailored to an individual hospital's specific needs. Bioquell works closely with hospital infection control teams to integrate Bioquell hydrogen peroxide vapor (HPV) technology with existing Norovirus remediation protocols or infection control bundles. A typical program consists of elements of Bioquell's core service offerings:
What is your evidence that using Bioquell will reduce Norovirus?
Norovirus transmission is known to have a large environmental component, as it survives in the environment for a long time and has an extremely low infective dose. There is anecdotal evidence from hospitals that using Bioquell has helped reduce the spread of Norovirus, though no research has yet been published. Bioquell is interested in collaborating with a hospital on such research.